Livewire Markets16h
The $100,000 Metal? Unlocking Investment Potential in Antimony’s Supply Crisis
China’s export ban has created a perfect storm. With soaring demand and vanishing supply, antimony is now a critical ...
The Armenian Reporter7h
Syros Pharmaceuticals (NASDAQ:SYRS) Earns Sell Rating from Analysts at StockNews.com
StockNews.com began coverage on shares of Syros Pharmaceuticals (NASDAQ:SYRS – Free Report) in a research report sent to ...